<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0509222584
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2003
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        PANADOL SINUS CAPLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        PARACETAMOL,PSEUDOEPHEDRINE HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        500,30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        OTC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        13.60
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Aspen Pharma Pty Ltd" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Aspen Pharma Pty Ltd
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 583]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ALNAGHI COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Haleon Australia Pty Ltd
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N02BE51
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Panadol Sinus is a white capsule-shaped tablet which<br />contains Paracetamol which is Analgesic and Antipyretic and<br />Pseudoephedrine which is a nasal decongestant. For the short<br />time relief of sinusitis symptoms including sinus headache, sinus<br />pain, and nasal congestion.<br />Also it used for relief of fever and body aches.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>a. Do not use Panadol Sinus Caplet if:<br />- You have previous history of hypersensitivity to paracetamol,<br />pseudoephedrine, or any of the other ingredients of Panadol Sinus.<br />- You have severe hypertension or severe coronary artery disease.<br />- You are taking other sympathomimetics (such as decongestants,<br />appetite suppressants, and amphetamine-like psychostimulants).<br />- You are taking or have taken in the past 2 weeks drug named<br />Monoamine Oxidase Inhibitors (MAOIs) as it may lead to<br />hypertensive crisis.<br />- You have severe renal impairment.<br />- There have been reports of acute systemic vasoconstrictive<br />events with pseudoephedrine. Significant examples include:<br />&bull; Acute Coronary Syndrome (ACS): Symptoms include sudden<br />chest pain, tightness, heavy sweating and dyspnoea at rest.<br />&bull; lschaemic colitis: Symptoms include sudden abdominal pain and<br />rectal bleeding.<br />&bull; Posterior reversible encephalopathy (PRES)/reversible cerebral<br />vasoconstriction syndrome (RCVS): Symptoms included<br />sudden onset of severe headache, nausea, vomiting, and visual<br />disturbances. Most cases improved or resolved within a few days<br />following appropriate treatment.<br />- Pseudoephedrine should be discontinued immediately and<br />medical advice sought if any signs/symptoms vasoconstrictive<br />events develop</p><p>b. Take special care with Panadol Sinus if:<br />You should consult your doctor before taking this product if:<br />- You have liver impairment ormild to moderate kidney impairment.<br />- You have cardiovascular disease, arrhythmias, hypertension,<br />hyperthyroidism, prostatic enlargement, diabetes, glaucoma or<br />phaeochromocytoma.<br />- You are taking beta-blockers or other antihypertensives.<br />- You have glutathione depleted states such as sepsis or you have<br />a severe infection as the use of Paracetamol may increase the risk<br />of metabolic acidosis. Signs of metabolic acidosis include:<br />- deep, rapid, difficult breathing<br />- Feeling sick (nausea), being sick (vomiting)<br />- Loss of appetite<br />Contact a doctor immediately if you get a combination of these<br />symptoms.<br />- There have been reports of ischaemic colitis with<br />Pseudoephedrine. Pseudoephedrine should be discontinued<br />immediately and medical advice sought if sudden abdominal pain,<br />rectal bleeding or other symptoms of ischaemic colitis develop.<br />- There have been rare cases of posterior reversible<br />encephalopathy (PRES)/reversible cerebral vasoconstriction<br />syndrome (RCVS) reported with sympathomimetic drugs,<br />including pseudoephedrine. Symptoms reported included<br />sudden onset of severe headache, nausea, vomiting, and visual<br />disturbances. Most cases improved or resolved within a few<br />days following appropriate treatment. Pseudoephedrine should<br />be discontinued, and medical advice sought immediately, if<br />signs/symptoms of PRES/RCVS<br />develop.<br />- If you experience sudden severe headache.<br />* This product contains 0.6 mg Sodium benzoate per tablet to be<br />taken into consideration by patients on controlled Sodium diet.<br />*Do not exceed the stated dose.<br />* This product contains Paracetamol and Pseudoephedrine. Do not<br />use with other products containing paracetamol or decongestants<br />products.<br />* Keep medication out of sight and reach of children.<br />* Please see your doctor if your symptoms persist, do not improve,<br />worsen or new symptoms occur.</p><p>C. Taking other medications:<br />- The liver toxic effects of Paracetamol may be increased by the<br />use of alcohol. Avoid drinking alcohol with this medicine.<br />- The anticoagulant effect of warfarin and other coumarins<br />may be enhanced by prolonged regular daily use of<br />paracetamol-containing products with increased risk of bleeding;<br />occasional doses have no significant effect.<br />- Concomitant administration of pseudoephedrine<br />hydrochloride-containing products and MAOIs (or within two<br />weeks of stopping of MAOI) may lead to hypertensive crisis.<br />- Concomitant use of this medication with sympathomimetic<br />agents (such as decongestants, appetite suppressants and<br />amphetamine-like psychostimulants) which interfere with the<br />catabolism of sympathomimetic amines, may occasionally cause a<br />rise in blood pressure.<br />- Pseudoephedrine-containing products may antagonise the<br />effect of certain classes of antihypertensives.<br />d. Pregnancy and lactation:<br />This product should not be used during pregnancy or while<br />breastfeeding without consulting your doctor.<br />Safe use of Pseudoephedrine in pregnancy has not been<br />established despite widespread use over many years.<br />Caution should be exercised by balancing the potential benefit<br />of treatment to the mother against any possible hazards to the<br />developing foetus.<br />Pseudoephedrine is excreted in breast milk in small amounts but<br />the effect of this on breast fed infants is unknown.</p><p>e. Driving and usingmachines:<br />&bull; This product can cause drowsiness, dizziness, or blurred vision.<br />You should not drive or operate machinery until you are sure<br />you are not affected.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Adults (including the elderly) and children aged 12 years and over:<br />- 1 to 2 caplets to be taken orally every 4 to 6 hours but do not<br />take more than<br />8 caplets in 24hours.<br />- Consult your doctor if symptoms persist for more than 7 days.<br />- Do not take more frequently than every 4 hours.</p><p>- Do not use in children under the age of 12 years.<br />- Do not exceed the stated dose.<br />Overdose<br />Seek medical advice immediately in the event of overdose even if<br />symptoms of overdose are not present.<br />Paracetamol:<br />Paracetamol overdose may cause liver failure. Immediate medical<br />management is required in the event of overdose, even if<br />symptoms of overdose are not present.<br />- In massive over dosage exceeding 10g of paracetamol may<br />cause liver damage. Early symptoms may include pallor, nausea,<br />vomiting, excessive sweating and general malaise.<br />- Clinical and laboratory evidence of liver damage may not be<br />apparent until 48 to 72 hours past ingestion.<br />Overdose should be promptly treated by gastric lavage followed<br />by intravenous N- acetylcysteine or methionine without waiting<br />for the results of plasma paracetamol levels.<br />- Additional antidote therapy is normally considered in light of<br />further plasma paracetamol levels and the time elapsed since<br />ingestion. In all cases of suspected overdose, prompt medical<br />attention is critical for adults as well as for children, even if you do<br />not notice any signs or symptoms.<br />Pseudoephedrine:<br />Pseudoephedrine overdose may result in symptoms due to central<br />nervous system and cardiovascular stimulation e.g. excitement,<br />restlessness, hallucinations, hypertension and arrhythmias. In<br />severe cases, psychosis convulsions, coma and hypertensive<br />crisis may occur. Serum Potassium levels may be low due to<br />extracellular shifts in Potassium.<br />Treatment should consist of standard supportive measures. Beta<br />blockers should reverse the cardiovascular complications and the<br />hypokalemia.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Stop using this product and consult your doctor immediately if:<br />Paracetamol:<br />- You experience allergic reactions such as skin rash or itching,<br />sometimes with breathing problems or swelling of the lips,<br />tongue, throat or face.<br />- You experience a skin rash or peeling, or mouth ulcers.<br />- You experience angioedema or Stevens Johnson syndrome.<br />- You have previously experienced breathing problems or<br />bronchospasm with aspirin or non steroidal anti-inflammatories,<br />and experience a similar reaction with this product.<br />- You experienced liver dysfunction related symptoms or signs.<br />- You experience unexplained bruising or bleeding.<br />Pseudoephedrine HCl:<br />- Nervousness, difficulty sleeping, dizziness, dry mouth, nausea<br />and vomiting, may occasionally occur.<br />- Rare reactions may include hallucinations, tachycardia,<br />palpitations, increased blood pressure (increase in systolic<br />blood pressure has been observed, at the therapeutic doses the<br />effects of Pseudoephedrine on blood pressure are not clinically<br />significant), rash, allergic dermatitis (such as bronchospapsm and<br />angioedema).<br />- Uncommon reactions such as agitation, restlessness, dysuria,<br />urinary retention(most likely to occur in those with bladder outlet<br />obstruction such as prostatic hypertrophy).<br />If any of the side effects gets serious, or if you notice any side<br />effects not listed in this leaflet, please contact your doctor or<br />pharmacist.</p><p>To report any side effect(s):<br />Kingdom of Saudi Arabia<br />-National Pharmacovigilance centre (NPC)<br />&bull; Fax: +966-11-205-7662<br />&bull; Reporting Hotline: 19999<br />&bull; E-mail: npc.drug@sfda.gov.sa<br />&bull; Website: https://ade.sfda.gov.sa<br />-Haleon Saudi Arabia - Head Office, Jeddah<br />&bull; Tel: +966-12-601-5444<br />&bull; Mobile: +966-53-553-3647<br />&bull; Email: mystory.sa@haleon.com<br />&bull; P.O. Box 48034, Jeddah 21572, Saudi Arabia</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>5. How to store Panadol Sinus<br />&bull; Keep out of the reach and sight of children.<br />&bull; Store Panadol Sinus at below 30&deg;C.<br />&bull; Medicines should not be disposed of via wastewater or<br />household waste. Ask your pharmacist how to dispose of<br />medicines no longer required. These measures will help to<br />protect the environment.<br />&bull; Protect from light and heat.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What Panadol Sinus contains<br />&bull; Active ingredients:<br />Paracetamol 500mg<br />Pseudophedrine Hydrochloride 30mg</p><p>&bull; Other non active ingredients:<br />Talc-Purified.<br />Povidone.<br />Starch-Pregelatinised maize. Sodium benzoate.<br />Starch-Maize. Stearic acid.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Pack size : 24’s ( 2 blisters x 12 caplets)
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Manufactured by: Aspen Pharma Pty Ltd, 286 &ndash; 302 Frankston &ndash;<br />Dandenong Road,<br />Dandenong South VIC 3175, Australia.<br />For Haleon Australia Pty limited, Australia.<br />Packed by: Glaxo Saudi Arabia Limited., Jeddah, Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                updated based GDS V12 Date of revision: 25 Feb 2023
leaflet revision date : October 2023
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>بانادول سينس هو أقراص بيضاء بشكل كبسولة وهي تحتوي على باراسيتامول وهو<br />مسكن وخافض للحرارة، سودوإيفيدرين وهو مزيل لإحتقان الأنف. على المدى القصير<br />هو مخفف لأعراض إلتهاب الجيوب الأنفية والتي تشمل الصداع الجيبي، آلام الجيوب<br />الأنفية، واحتقان الأنف. أيضا يستخدم في تخفيف الحرارة وآلام الجسم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>أ. لا تستخدم بانادول سينس أقراص في حال:<br />- تعاني من حساسية مفرطة للباراسيتامول، السودوايفيدرين أو أي من مكونات بانادول<br />سينس.<br />- تعاني من ارتفاع في ضغط الدم أو مرض قلب خطير.<br />- تتناول أدوية أخرى محفزة للجهاز السمباثاوي )مثل مزيلات الاحتقان، مثبطات الشهية،<br />والمنشطات النفسية مثل<br />الأمفيتامين(.<br />- تتناول أو قد تناولت خلال الأسبوعين الماضيين مثبطات المونوأمين أوكسيديز، لأن ذلك قد<br />يؤدي الى نوبة ارتفاع<br />ضغط الدم.<br />- لديك فشل كلوي حاد.<br />- كانت هناك تقارير عن أحداث تضيق الأوعية الدموية الجهازية الحادة باستخدام<br />السودوإيفيدرين. تشمل الأمثلة الهامة ما يلي:</p><p>تشمل الأعراض ألمًا مفاجئًا في الصدر، :)ACS( &bull; متلازمة الشريان التاجي الحادة<br />وضيقًا، وتعرقًا شديدًا، وصعوبة في التنفس أثناء الراحة.<br />&bull; التهاب القولون الإقفاري: تشمل الأعراض آلام البطن المفاجئة ونزيف المستقيم.<br />متلازمة تضيق الأوعية /)PRES( &bull; متلازمة الاعتلال الدماغي الخلفي القابل للارتداد<br />تشمل الأعراض الصداع الشديد المفاجئ، :)RCVS( الدموية الدماغية القابل للارتداد<br />والغثيان، والتقيؤ، والاضطرابات البصرية. وتحسَّنت غالبية الحالات أو تعافت خلال<br />بضعة أيام بعد تلقي العلاج المناسب.<br />- يجب التوقف عن تناوُل السودوإيفيدرين على الفور وطلب المشورة الطبية إذا حدثت<br />إصابة بأيٍّ من علامات/أعراض تضيّق الأوعية الدموية.</p><p>ب. تناول بانادول سينس بحذر في حال:<br />استشر طبيبك قبل تناول هذا المنتج في حال:<br />- تعاني من فشل كبدي أو فشل كلوي خفيف أو متوسط.<br />- تعاني من مرض قلبي، عدم انتظام ضربات القلب، ارتفاع ضغط الدم، فرط نشاط<br />الغدة الدرقية، تضخم البروستاتا، مرض السكري، المياه الزرقاء أو تورم الغدة<br />الكظرية.<br />- تناول مثبطات مستقبلا بيتا أو أدوية أخرى مضادة لإرتفاع الضغط.<br />- في حال تعاني من حالات استنفاد الغلوتاثيون أو من إلتهاب حاد كون استخدام<br />الباراسيتامول قد يزيد من خطر الإصابة بالحماض الأيضي. إن علامات الحماض<br />الأيضي تشمل:<br />- التنفس السريع والعميق والصعوبة في التنفس.<br />- الغثيان والتقيؤ.<br />- فقدان الشهية.<br />اتصل بالطبيب فورا في حال الشعور بهذه الأعراض.<br />- تم الابلاغ عن حالات من التهاب القولون الأقفاري مع استخدام السودوإيفيدرين. يجب<br />التوقف عن استخدام السودوإيفيدرين فورا واستشارة الطبيب في حال الشعور بآلام مفاجئة<br />في المعدة، أو نزف المستقيم أو أي أعراضأخرى مرتبطة بالتهاب القولون الأفقاري.<br />(PRES(/ - تم الابلاغ أيضا عن حالات نادرة من الالتهاب السحائي الخلفي المرتجع<br />مع استخدام الأدوية محفزة )RCVS( متلازمة تضيق الأوعية الدماغية المرتجعة<br />للجهاز السمباثاوي بما فيها السودوإيفيدرين. تشمل الأعراض التي أبلغ عنها الصداع<br />الشديد المفاجئ، الغثيان، التقيؤ، والاضطرابات البصرية. معظم الحالات تحسنت أو اختفت<br />في غضون بضعة أيام من تلقي العلاج المناسب. يجب التوقف عن استعمال<br />السودوإيفيدرين ومراجعة الطبيب فورا في حال الشعور بعلامات أو أعراض الالتهاب<br />متلازمة تضيق الأوعية الدماغية المرتجعة )PRES(/ السحائي الخلفي المرتجع<br />.(RCVS(</p><p>- الاصابة بصداع شديد ومفاجيء.<br />* هذا المنتج يحتوي على ٠٫٦ ملجم بنزوات الصوديوم في القرص الواحد لتؤخذ بعين<br />الاعتبار من قبل المرضى الذين يتبعون نظام غذائي ذو نسبة محددة من الصوديوم.<br />* لا تتجاوز الجرعة المحددة.<br />* هذا المنتج يحتوي على باراسيتامول وسودوايفيدرين. لا تستخدم منتجات أخرى<br />تحتوي على باراسيتامول أو منتجات مزيلة للاحتقان.<br />* احفظ المنتج بعيدا عن متناول ونظر الأطفال.<br />* استشر طبيبك في حال عدم زوال الأعراض، عدم وجود تحسن، تفاقمت أو ظهور<br />أعراض جديدة.</p><p>ج. تناول أدوية أخرى:<br />- قد تزيد الآثار السامة المبرتبطة بتناول الباراسيتامول على الكبد عند تناول الكحول.<br />تجنب تناول الكحول مع هذا الدواء.<br />- يمكن تعزيز تأثير الأدوية المضادة للتجلط والوارفارين وغيرها من الكومارينز إثر<br />الاستعمال اليومي الطويل المنتظم للباراسيتامول مع زيادة في خطر النزيف، الجرعات<br />العرضية ليس لها تأثير ملحوظ.<br />- ان التناول المتزامن للمنتجات التي تحتوي على السودوايفيدرين هيدروكلورايد<br />أو خلال الاسبوعين من التوقف عن استخدام ( )MAOI( ومثبطات المونوامين اوكسيديز<br />مثبطات المونوأمين أوكسيديز( قد يؤدي إلى نوبة ارتفاع في ضغط الدم.<br />- ان تناول أدوية أخرى محفزة للجهاز السمباثاوي )مثل مزيلات الاحتقان، مثبطات<br />الشهية، والمنشطات النفسية مثل الأمفيتامين( التي تتداخل مع تقويض أمينات الجهاز<br />السمباثاوي قد يؤدي احيانا الى ارتفاع ضغط الدم.<br />- المنتجات التي تحتوي على سودوايفيدرين قد تعارض تأثير بعض الأدوية المضادة<br />لارتفاع الضغط.<br />د. الحمل والإرضاع:<br />يجب عدم استخدام هذا المنتج أثناء الحمل والرضاعة بدون استشارة طبية.<br />ھ. القيادة واستخدام الآلات:<br />هذا المنتج قد يسبب النعاس، والدوخة وعدم وضوح الرؤية. ينصح المرضى بعدم<br />القيادة أو العمل على الآلات حتى التأكد من عدم الإصابة بأي حالة مرضية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>3. كيفية تناول/استعمال كبسولات بانادول سينس<br />التناول عن طريق الفم فقط.<br />البالغين )ويشمل المسنين( والأطفال من عمر ١٢ سنة وما يزيد:<br />- تناول قرص أو قرصين عن طريق الفم مرة كل ٤ الى ٦ ساعات ولكن لا يجوز تناول أكثر<br />من ٨ أقراص خلال ٢٤ ساعة.<br />- استشر طبيبك اذا استمرت الأعراض أكثر من ٧ أيام.<br />- لا تتناول أكثر من مرة كل ٤ ساعات.<br />- لا تستخدمه للأطفال دون ١٢ سنة من العمر.<br />- لا تتجاوز الجرعة الموصوفة.<br />الجرعة المفرطة<br />يتطلب اتخاذ تدابير صحية فورية في حالة الجرعة المفرطة حتى وإن لم تظهر<br />الأعراض المرضية لها.<br />باراسيتامول:<br />إن تناول جرعة مفرطة من الباراسيتامول قد يؤدي الى تلف الكبد. يتطلب اتخاذ اتخاذ<br />تدابير طبية فورية في حالة الجرعة المفرطة خشية حدوث تلف الكبد، حتى وإن لم<br />تظهر أعراض الجرعة المفرطة.</p><p>- في حالة تناول جرعات مفرطة عالية تتجاوز ١٠ غرام من باراسيتامول قد يسبب<br />تلف الكبد، والأعراض المبكرة قد تشمل الشحوب، والغثيان، والقيء، التعرق الغزير<br />والوعكة العامة.<br />- الأدلة السريرية والمختبرية لتلف الكبد قد لا تكون واضحة إلا بعد ٤٨ إلى ٧٢ ساعة<br />عقب الابتلاع، ينبغي أن تعالج الجرعة المفرطة فورا عن طريق غسل المعدة يليها<br />إعطاء الترياق إن-أسيتيل سيستايين أو ميثيونين بالوريد دون انتظار نتائج مستويات<br />الباراسيتامول في البلازما.<br />عادة يجب إعطاء ترياق إضافي في ضوء مستويات الباراستيامول الإضافي في<br />البلازما والوقت المنقضي بعد التسمم.<br />في جميع الحالات التي يشتبه فيها تناول جرعة مفرطة، تكون العناية الطبية العاجلة<br />أمرا حاسما للكبار وكذلك للأطفال، حتى وإن لم تلاحظ أية علامات أو أعراض.<br />السودوايفيدرين:<br />تؤدي الجرعة المفرطة من الودوإيفيدرين إلى أعراض ناتجة عن تحفيز الجهاز<br />العصبي المركزي والقلب والأوعية الدموية مثل الإثارة<br />والأرق، والهلوسة، اضطراب النظم وارتفاع ضغط الدم،<br />وتشمل الحالات الشديدة التشنجات، الذهان، والغيبوبة<br />وارتفاع ضغط الدم. وقد تكون مستويات مصل<br />البوتاسيوم منخفضة بسبب خروج البوتاسيوم من الخلايا،<br />يجب العلاج وفقا للتدابير الداعمة الاعتيادية. يجب أن<br />تعكس مثبطات مستقبلات بيتا المضاعفات القلبية<br />والأوعية الدموية ونقص البوتاسيوم في الدم.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>توقف عن استخدام المنتج واستشر طبيبك فورا في حال:<br />باراسيتامول:<br />- حدوث ردود فعل حساسية مثل الطفح الجلدي أو الحكة،<br />وأحيانا مع مشاكل في التنفس أو تورم في الشفتين<br />واللسان والحلق أو الوجه.<br />- حدوث طفح جلدي أو تقشير أو تقرحات في الفم.<br />- الاصابة بالوذمة الوعائية او متلازمة ستيفين جونسون.<br />- واجهت مسبقا مشاكل في التنفس مع تناول الأسبرين أو<br />مضادات الالتهاب غير الستيرويدية، وحدث ردة فعل<br />مشابهة مع هذا المنتج.<br />- قصور في وظيفة الكبد أو أي أعراض أو علامات مرتبطة بذلك.<br />- ظهور كدمات غير مبررة أو نزيف.<br />السودوايفيدرين:<br />- الاثارة العصبية، الأرق، دوخة، جفاف الفم، غثياء وقيء قد تحدث في بعض الأحيان.<br />- آثار جانبية نادرة وقد تشمل الهلوسة، ارتفاع ضربات القلب، خفقان القلب، ارتفاع<br />ضغط الدم )وقد لوحظ ارتفاع في ضغط الدم الانقباضي، عند الجرعات العلاجية لا<br />يوجد آثار هامة سريريا للاسودوايفيدرين على الضغط الدم(، حكة، حساسية التهاب<br />الجلد )مثل التشنج القصبي والوذمة الوعائية(.<br />- آثار جانبية غير منتشرة مثل التهيج وعدم الراحة، عسر البول، احتباس البول )غالبا<br />تحدث في حالات انسداد منفذ المثانة مثلا كتضخم البروستاتا(.<br />في حال وجود أي آثار جانبية أو ملاحظة آثار جانبية غير مذكورة في هذه النشرة،<br />عليك التواصل مع طبيبك المعالج او الصيدلي.</p><p>للإبلاغ عن أي آثار جانبية:<br />المملكة العربية السعودية<br />(NPC( - المركز الوطني للتيقظ والسلامة الدوائية<br />+ 966-11-205- فاكس: 7662<br />الاتصال بالرقم الموحد: 19999<br />npc.drug@sfda.gov.sa : البريد الإلكتروني<br />https://ade.sfda.gov.sa : الموقع الإلكتروني<br />- ھاليون السعودية العربية &ndash; المكتب الرئيسي، جدة.<br />+966-12-601- هاتف: 5444<br />+966-53-553- جوال: 3647<br />mystory.sa@haleon.com : البريد الإلكتروني<br />ص.ب. 48034 ، جدة 21572 ، المملكة العربية السعودية</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>- وضع المنتج بعيدا عن متناول ونظر الأطفال.<br />- يحفظ في درجة حرارة أقل من ۳٠ درجة مئوية.<br />- لا ينبغي أن يتم التخلص من الأدوية من خلال مياه الصرف الصحي أو النفايات<br />المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد مطلوبة. ومن شأن<br />هذه التدابير أن تساعد على حماية البيئة.<br />- احفظه بعيدا عن الضوء والحرارة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>على ماذا يحتوي بانادول سينس<br />&bull; المواد الفعالة:<br />باراسيتامول ٥٠٠ ملجم.<br />اسودوايفيدرين هايدروكلورايد ۳٠ ملجم.<br />&bull; مكونات أخرى:<br />تلك منقى، بوفيدون، نشاء ما قبل الهلام، بنزوات الصوديوم،حمض السيتريك.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>حجم العبوة : ٢٤ قرصا ) ٢ شريط ١٢ قرص(</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>العلامات التجارية مملوكة/مرخصة لصالح مجموعة شركات ھاليون<br />302 فرانكستون &ndash; طريق &ndash; ليميتد، 286 Pty تم التصنيع بواسطة أسبن فارما<br />أستراليا ،VIC داندينونج، جنوب داندينونج 3175<br />لصالح ھاليون استراليا<br />لميتد، استراليا Pty<br />تعبئة: جلاكسو العربية السعودية المحدودة، جدة، السعودية</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            GDS V تم التحديث إستنادا إًلى الإصدار: 12
25 Feb تاريخ المراجعة: 2023
تاريخ مراجعة النشرة : اكتوبر 2023
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Panadol Sinus
Paracetamol
Pseudoephedrine Hydrochloride
Chlorphenamine Maleate

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Panadol Allergy Sinus Tablets contain pseudoephedrine hydrochloride 30 mg, paracetamol 500 mg, and chlorphenamine maleate 2 mg.
Excipient with known effect: sodium benzoate as a preservative.
For the full list of excipients, see Section 6.1 List of excipients.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Panadol Allergy Sinus Tablets are white, capsule-shaped tablets with flat edges, one face marked with ‘PANADOL’ and ‘C&F C&F (upside down)’ on the other side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Panadol Allergy Sinus Tablets are used for the temporary relief of sinusitis symptoms, nasal congestion and allergic symptoms such as runny nose, sneezing, itchy and watery eyes.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Adults and children 12 years and over:</strong></p><p>2 capsule-shaped tablets (caplets) taken with water every 6 hours as necessary, maximum 8 caplets within 24 hours.</p><p><strong>Use in adults</strong></p><p>Paracetamol should not be taken for more than a few days at a time except on medical advice.</p><p><strong>Use in children aged 12 to 17 years</strong></p><p>Paracetamol should not be taken for more than 48 hours except on medical advice. Do not use in children below 12 years of age.</p><p>Do not exceed the stated dose or frequency of dosing. Minimum dosage interval: 6 hours.</p><p>Should not be used with other medicines containing paracetamol, pseudoephedrine, chlorphenamine, decongestants or antihistamines, including cough and cold medicines.</p><p>Seek medical advice if symptoms persist for more than 7 days.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                This product is contraindicated for use in patients:
•	With a previous history of hypersensitivity to paracetamol, pseudoephedrine, chlorphenamine, other antihistamines or any of the excipients included in the product.
•	With severe hypertension or coronary artery disease.
•	Who are taking Monoamine Oxidase inhibitors (MAOIs) or who have taken MAOIs within the previous 14 days (see Section 4.5 Interactions with other medicines and other forms of interactions).
•	With stenosing peptic ulcer.
•	With symptomatic prostatic hypertrophy.
•	With bladder neck obstruction.
•	With pyloroduodenal obstruction.
•	Who are taking other sympathomimetics (such as decongestants, appetite
•	suppressants and amphetamine-like psychostimulants (see Section 4.5 Interactions with other medicines and other forms of interactions).
•	With severe renal impairment.
•	Narrow-angle glaucoma.
•	Newborns or premature infants.
•	Infants less than 12 months of age.
•	Lactating women.
This product should not be used with other medicines containing paracetamol, pseudoephedrine, chlorphenamine or other medicines for the relief of colds, congestion or blocked nose.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Identified precautions</strong></p><p>This product should be used with caution in patients with:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cardiovascular disease -coronary heart disease, ischaemic heart disease</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Arrhythmias</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypertension</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prostatic hypertrophy</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hyperthyroidism</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diabetes mellitus</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Raised intra-ocular pressure including glaucoma</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Epilepsy</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bronchitis</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bronchiectasis</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bronchial asthma</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hepatic or renal impairment. Caution should be exercised in patients with kidney impairment and in those with hepatic impairment due to the paracetamol content of this medicine. Underlying liver disease increases the risk of paracetamol related liver damage. Patients who have been diagnosed with liver or kidney impairment must seek medical advice before taking this medication.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In patients with glutathione depleted states such as sepsis, the use of paracetamol may increase the risk of metabolic acidosis</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Phaeochromocytoma</p><p>Use with caution in patients taking beta-blockers or other anti-hypertensives because of the pseudoephedrine content (see 4.5 Interactions with other medicines and other forms of interactions). Concurrent use of alcohol should be avoided due to the chlorphenamine content.</p><p>There have been reports of acute systemic vasoconstrictive with pseudoephedrine. Significant examples include:</p><p>Acute Coronary Syndrome (ACS): Symptoms include sudden chest pain, tightness, heavy sweating and dyspnoea at rest.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ischaemic colitis: Symptoms include sudden abdominal pain and rectal bleeding.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Posterior reversible encephalopathy (PRES)/reversible cerebral vasoconstriction syndrome (RCVS): Symptoms included sudden onset of severe headache, nausea, vomiting, and visual disturbances. Most cases improved or resolved within a few days following appropriate treatment.</p><p>Pseudoephedrine should be discontinued immediately and medical advice sought if any signs/symptoms vasoconstrictive events develop.</p><p>Concurrent use with drugs which cause sedation, such as anxiolytics and hypnotics may cause an increase in sedative effects, therefore medical advice should be sought before taking chlorphenamine concurrently with these medicines (see 4.5 Interactions with other medicines and other forms of interactions).</p><p>This product should not be used with other antihistamine containing products, including antihistamine containing cough and cold medications, because of the chlorphenamine content.</p><p>Medical advice should be sought if the symptoms persist, or is accompanied by a high fever, skin rash or persistent headache.</p><p>If symptoms persist, medical advice must be sought.</p><p>Keep out of sight and reach of children.</p><p>Patients should be advised not to drive or operate machinery if affected by dizziness.</p><p>Refer to 4.5 Interactions with other medicines and other forms of interactions for additional information.</p><p><strong>Use in hepatic impairment</strong></p><p>Caution should be exercised in patients with hepatic impairment due to the paracetamol content of this medicine.</p><p>Underlying liver disease increases the risk of paracetamol-related liver damage.</p><p>Patients who have been diagnosed with liver impairment must seek medical advice before taking this medication.</p><p><strong>Use in renal impairment</strong></p><p>Caution should be exercised in patients with kidney impairment due to the paracetamol content of this medicine.</p><p>Patients who have been diagnosed with kidney impairment must seek medical advice before taking this medication.</p><p>This product is contraindicated for use in patients with severe renal impairment.</p><p><strong>Use in the elderly</strong></p><p>No data available.</p><p><strong>Paediatric use</strong></p><p>Do not give to children under 12 years of age.</p><p><strong>Effects on laboratory tests</strong></p><p>No data available.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Paracetamol</strong></p><p>The following interactions with paracetamol have been noted:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The anticoagulant effect of warfarin and other coumarins may be enhanced by prolonged regular daily use of paracetamol-containing products with increased risk of bleeding; occasional doses have no significant effect. Anticoagulant dosage may require reduction if paracetamol and anticoagulants are taken for a prolonged period of time.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Paracetamol absorption is increased by substances that increase gastric emptying, e.g. metoclopramide.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Paracetamol absorption is decreased by substances that decrease gastric emptying, e.g. propantheline, antidepressants with anticholinergic properties, and narcotic analgesics.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Paracetamol may increase chloramphenicol concentrations.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The risk of paracetamol toxicity may be increased in patients receiving other potentially hepatotoxic drugs or drugs that induce liver microsomal enzymes such as alcohol and anticonvulsant agents.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Paracetamol excretion may be affected and plasma concentrations altered when given with probenecid.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Colestyramine reduces the absorption of paracetamol if given within 1 hour of paracetamol.</p><p><strong>Pseudoephedrine</strong></p><p>The following interactions with pseudoephedrine have been noted:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Antidepressant medication eg tricyclic antidepressants and monoamine oxidase inhibitors (MAOIs) &ndash; may cause a serious increase in blood pressure or hypertensive crisis.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Concomitant administration of pseudoephedrine and MAOIs (or within two weeks of stopping of MAOI) may lead to hypertensive crisis. See Section 4.3 Contraindications.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other sympathomimetic agents, such as decongestants, appetite suppressants and amphetamine-like psycho-stimulants which interfere with the catabolism of sympathomimetic amines may occasionally cause a rise in blood pressure. See 4.3 Contraindications.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pseudoephedrine may antagonise the effect of certain classes of antihypertensives (eg beta blockers, methyl-dopa, reserpine, debrisoquine, guanethidine). See Section 4.4 Special warnings and precautions for use.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; methyldopa and &beta;-blockers &ndash; may cause an increase in blood pressure.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; urinary acidifiers enhance elimination of pseudoephedrine.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; urinary alkalinisers decrease elimination of pseudoephedrine.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pseudoephedrine-containing products may antagonise the effect of certain classes of antihypertensives.</p><p><strong>Chlorphenamine maletate</strong></p><p>The following interactions with chlorphenamine maleta have been noted:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Central nervous system (CNS) depressants (alcohol, sedatives, opioid analgesics, hypnotics) &ndash; may cause an increase in sedation effects.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs) &ndash; may prolong and intensify the anticholinergic and CNS depressive effects</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Chlorphenamine</strong> when taken with monoamine oxidase inhibitors (MAOIs) may cause a decrease in blood pressure</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Chlorphenamine</strong> when taken concomitantly with phenytoin may cause a decrease in phenytoin elimination and can lead to phenytoin toxicity</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Effects on fertility</strong></p><p>No Data available.</p><p><strong>Use in pregnancy &ndash; Pregnancy Category B2</strong></p><p>Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human foetus having been observed. Studies in animals are inadequate or may be lacking, but available data shows no evidence of an increased occurrence of foetal damage.</p><p>Paracetamol &ndash; Category A</p><p>Drugs which have been taken by a large number of pregnant women and women of childbearing age without any proven increase in the frequency of malformations or other direct or indirect harmful effects on the foetus having been observed.</p><p>This product should be used in pregnancy only if the potential benefits to the patient are weighed against the possible risk to the foetus.</p><p>This product should not be used in pregnancy without medical advice.</p><p><strong>Use in lactation.</strong></p><p>This product should not be used whilst breastfeeding without medical advice Paracetamol is excreted in small amounts (&lt; 0.2%) in breast milk but the effect of this on breast fed infants is unknown. Maternal ingestion of paracetamol in usual analgesic doses does not appear to present a risk to the breastfed infants.</p><p>Pseudoephedrine is secreted in breast milk in small amounts. It has been estimated that 0.5% to 0.7% of a single dose of pseudoephedrine ingested by the mother will be excreted in the breast milk over 24 hours. Therefore, it is not recommended for breastfeeding mothers unless the potential benefits to the patient are weighed against the possible risk to the infant.</p><p>Chlorphenamine Maleate and other histamines may inhibit lactation and is excreted in breast milk. Therefore it is not recommended for breastfeeding mothers unless the potential benefits to the patient are weighed against the possible risk to the infant.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Chlorphenamine may cause drowsiness, dizziness, blurred vision and CNS depressive effects including sedation and impaired performance (impaired driving performance, incoordination, reduced motor skills and impaired information processing). Performance may be impaired in the absence of sedation and may persist the morning after a night time dose. Patients should be advised not to drive or operate machinery if affected. Due to Chlorphenamine content of this product, alcohol should be avoided. (See 4.5 Interactions with other medicines and other forms of interactions).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse events from extensive post-marketing experience at therapeutic/labelled dose and considered attributable are tabulated below by System Organ Class and frequency.</p><p>The following convention has been utilised for the classification of undesirable effects: very common (&gt;/= 1/10), common (&gt;= 1/100, &lt;1/10), uncommon (&gt;=1/1000, &lt;1/100), rare (&gt;= 1/10000, &lt;1/1000), very rare (&lt;1/10000), not known (cannot be estimated from the available data).</p><p>Adverse event frequencies have been estimated from spontaneous reports received through post-marketing data.</p><p><strong>Paracetamol</strong></p><table border="0" cellspacing="0" cellpadding="0" style="width:523px"><tbody><tr><td style="vertical-align:top"><p>Body System</p></td><td style="vertical-align:top"><p>Undesirable effect</p></td><td style="vertical-align:top"><p>Frequency</p></td></tr><tr><td style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top"><p>Thrombocytopaenia</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p>Immune System disorders</p></td><td style="vertical-align:top"><p>Anaphylaxis</p><p>Cutaneous hypersensitivity reactions including among others, skin rashes, angioedema, Stevens Johnson syndrome and Toxic Epidermal Necrolysis</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>Bronchospasm in patients sensitive to aspirin and other NSAIDs.</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p>Hepatobiliary disorders</p></td><td style="vertical-align:top"><p>Hepatic dysfunction</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr></tbody></table><p><strong>Pseudoephedrine</strong></p><table border="0" cellspacing="0" cellpadding="0" style="width:528px"><tbody><tr><td style="vertical-align:bottom"><p>Body System</p></td><td style="vertical-align:bottom"><p>Undesirable effect</p></td><td style="vertical-align:bottom"><p>Frequency</p></td></tr><tr><td style="vertical-align:top"><p>Psychiatric disorders</p></td><td style="vertical-align:top"><p>Nervousness, Insomnia</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>Agitation, restlessness</p></td><td style="vertical-align:bottom"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Hallucinations</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Nervous System Disorders</p></td><td style="vertical-align:top"><p>Dizziness, tremors</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Cardiac Disorders</p></td><td style="vertical-align:top"><p>Tachycardia or arrhythmia, palpitations</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top"><p>Increased blood pressure<sup>1</sup></p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal Disorders</p></td><td style="vertical-align:top"><p>Vomiting, Dry Mouth, Nausea</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:bottom"><p>Skin and Subcutaneous Tissue Disorders</p></td><td style="vertical-align:top"><p>Rash, Allergic dermatitis<sup>2</sup></p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Renal and Urinary Disorders</p></td><td style="vertical-align:top"><p>Dysuria, Urinary retention<sup>3</sup></p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr></tbody></table><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increases in systolic blood pressure have been observed. At therapeutic doses, the effects of pseudoephedrine on blood pressure are not clinically significant.</p><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A variety of allergic skin reactions, with or without systemic features such as bronchospasm and angioedema have been reported following use of pseudoephedrine.</p><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Urinary retention is most likely to occur in those with bladder outlet obstruction, such as prostatic hypertrophy.</p><p><strong>Chlorphenamine maleate</strong></p><table border="0" cellspacing="0" cellpadding="0" style="width:611px"><tbody><tr><td style="vertical-align:top"><p><strong>Body System</strong></p></td><td style="vertical-align:top"><p><strong>Undesirable Effect</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>Sedation, somnolence</p><p>Disturbance in attention, abnormal coordination, dizziness, headache</p></td><td style="vertical-align:top"><p>Very common</p><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Eye disorders</p></td><td style="vertical-align:top"><p>Blurred vision</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Nausea, dry mouth</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>Fatigue</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>CNS stimulatory effects</p></td><td style="vertical-align:top"><p>Anxiety, hallucinations, appetite stimulation, muscle dyskinesias, and activation of epileptogenic foci.</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Anticholinergic effects</p></td><td style="vertical-align:top"><p>Dryness of the eyes and nose, blurred vision, urinary hesitancy and retention, constipation and tachycardia</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>Allergic reactions, angioedema, anaphylactic reactions</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Metabolism and nutritional disorders</p></td><td style="vertical-align:top"><p>Anorexia</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Psychiatric disorders</p></td><td style="vertical-align:top"><p>Confusion*, excitation*, irritability*, nightmares*</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top"><p>Hypotension</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>Thickening of bronchial secretions</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Vomiting, abdominal pain, diarrhoea, dyspepsia</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous disorders</p></td><td style="vertical-align:top"><p>Exfoliative dermatitis, rash, urticaria, photosensitivity</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal and connective tissue disorder</p></td><td style="vertical-align:top"><p>Muscle twitching, muscle weakness</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>Chest tightness</p></td><td style="vertical-align:top"><p>Not known</p></td></tr></tbody></table><p>*Children and the elderly are more susceptible to neurological anticholinergic effects and paradoxical excitation (e.g. increased energy, restlessness, nervousness).</p><p>The elderly are more likely to have central nervous system (CNS) depressive side effects, including confusion.</p><p>&nbsp;</p><p><strong>To report any side effect(s):</strong></p><p><strong><em>Kingdom of Saudi Arabia</em></strong></p><p><strong>-National Pharmacovigilance centre (NPC)</strong></p><p>Fax: +966-11-205-7662</p><p>Reporting Hotline: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa</p><p><strong>-Haleon Saudi Arabia - Head Office, Jeddah</strong></p><p>Tel:&nbsp; +966-12-601-5444</p><p>Mobile: +966-53-553-3647</p><p>Email: mystory.sa@haleon.com &nbsp;<u>&nbsp;</u></p><p>P.O. Box 48034, Jeddah 21572, Saudi Arabia</p><p><strong>For any information about this medicinal product, please contact</strong><strong>:</strong></p><p><strong>Haleon Saudi Arabia - Head Office, Jeddah</strong></p><p>Tel:&nbsp; +966-12-601-5444</p><p>Email: &nbsp;mystory.sa@haleon.com</p><p>P.O. Box 48034, Jeddah 21572, Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Poisons Information Centre</strong></p><p>If an overdose is taken or suspected, immediately contact the Poisons Information Centre (in Australia, call 131 126) for advice, or the patient should go to the hospital straight away even if they feel well because of the risk of delayed, serious liver damage. See Section 4.8 Adverse effects (undesirable effects).</p><p><strong>Treatment-Paracetamol</strong></p><p>Paracetamol overdose may cause liver failure which can lead to liver transplant or death, and rarely, acute renal tubular necrosis. Acute pancreatitis has been observed with hepatic dysfunction.</p><p>Immediate medical management is required in the event of overdose, even if the symptoms of overdose are not present.</p><p>Administration of N-acetylcysteine or methionine may be required.</p><p><strong>Treatment-Pseudoephedrine</strong></p><p>Pseudoephedrine overdose may result in symptoms due to central nervous system and cardiovascular stimulation e.g. excitement, restlessness, hallucinations, hypertension and arrhythmias. In severe cases, psychosis, convulsions, coma and hypertensive crisis may occur. Serum potassium levels may be low due to the extracellular to intracellular shifts in potassium.</p><p>Treatment should consist of standard supportive measures.</p><p><strong>Treatment-Chlorphenamine maleate</strong></p><p>Overdose is likely to result in effects similar to those listed under adverse reactions. Additional symptoms may include paradoxical excitation, toxic psychosis, convulsions, apnoea, dystonic reactions and cardiovascular collapse including arrhythmias.</p><p>Treatment should be symptomatic and supportive and directed toward specific symptoms. Convulsions and marked CNS stimulation should be treated with parenteral diazepam.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Mechanism of action</strong></p><p>Paracetamol is a p-aminophenol derivative that exhibits analgesic and antipyretic activity. It does not possess anti-inflammatory activity. Paracetamol is thought to produce analgesia through a central inhibition of prostaglandin synthesis.</p><p>Pseudoephedrine has direct- and indirect- sympathomimetic activity and is an effective decongestant in the upper respiratory tract. It is a stereoisomer of ephedrine and has a similar action, but has been found to have less pressor activity and fewer central nervous system (CNS) effects.</p><p>Sympathomimetic agents are used as nasal decongestants to provide symptomatic relief. They act by causing vasoconstriction resulting in redistribution of local blood flow to reduce oedema of the nasal mucosa, thus improving ventilation, drainage and nasal stuffiness.</p><p>Chlorphenamine Maleate competes with histamine at central and peripheral histamine<sub>1</sub>-receptor sites, preventing the histamine-receptor interaction and subsequent mediator release.</p><p>It is a highly lipophilic molecule that readily crosses the blood-brain barrier. It is highly selective for histamine<sub>1</sub>-receptors but has little effect on histamine<sub>2</sub> or histamine<sub>3</sub>-receptors.</p><p>Chlorphenamine Maleate also activates 5-hydroxytryptamine (serotonin) and &alpha;-adrenergic receptors and blocks cholinergic receptors.</p><p><strong>Clinical trials</strong></p><p>No data available</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Paracetamol</strong></p><p>Paracetamol is readily absorbed from the gastrointestinal tract with peak plasma concentrations occurring about 10 to 60 minutes after oral administration. Paracetamol is distributed into most body tissues. Plasma protein binding is negligible at usual therapeutic doses but increases with increasing doses. The elimination half-life varies from about 1 to 3 hours.</p><p>Paracetamol is metabolised extensively in the liver and excreted in the urine mainly as inactive glucuronide and sulphate conjugates. Less than 5% is excreted unchanged. The metabolites of paracetamol include a minor hydroxylated intermediate which has hepatotoxic activity. This intermediate metabolite is detoxified by conjugation with glutathione, however, it can accumulate following paracetamol over dosage (more than 150mg/kg or 10g total paracetamol ingested) and if left untreated can cause irreversible liver damage.</p><p>Paracetamol is metabolised differently by premature infants, newborns, infants and young children compared to adults, the sulphate conjugate being predominant.</p><p><strong>Pseudoephedrine</strong></p><p>Pseudoephedrine is readily absorbed from the gastrointestinal tract. It is largely excreted unchanged in the urine together with small amounts of its hepatic metabolite. It has a half- life of about 5-8 hours; elimination is enhanced and half-life reduced accordingly in acid urine. Small amounts are distributed into breast milk.</p><p><strong>Chlorphenamine maleate</strong></p><p>Chlorphenamine maleate is absorbed relatively slowly from the gastrointestinal tract, with peak plasma concentrations occurring about 2.5 to 6 hours after oral administration. Chlorphenamine appears to undergo considerable first-pass metabolism. Bioavailability is low, values of 25 to 50% having been reported. About 70% of Chlorphenamine in the circulation is bound to plasma proteins. There is wide inter-individual variation in the pharmacokinetics of Chlorphenamine; half-life values ranging from 2 to 43 hours have been reported. Chlorphenamine is widely distributed in the body and enters the CNS.</p><p>Chlorphenamine maleate is metabolised extensively. Metabolites include desmethyl- and didesmethylChlorphenamine. Unchanged drug and metabolites are excreted primarily in the urine; excretion is dependent on urinary pH and flow rate. Only trace amounts have been found in the faeces.</p><p>A duration of action of 4 to 6 hours has been reported; this is shorter than may be predicted from pharmacokinetic parameters.</p><p>More rapid and extensive absorption, faster clearance, and a shorter half-life have been reported in children compared to adults.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Genotoxicity</strong></p><p>No data available.</p><p><strong>Carcinogenicity</strong></p><p>No data available.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Panadol Allergy Sinus Tablets contain the excipients:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purified talc</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Maize starch</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pregelatinised maize starch</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stearic acid</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Povidone</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Silicon dioxide</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sodium benzoate</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Incompatibilities were either not assessed or not identified as part of the registration of this medicine. Refer to Section 4.5 &ndash; Interactions with other medicines and other forms of interactions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 Years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Panadol Allergy Sinus Tablets are available in blister packs of the following sizes:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 24 tablets</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In Australia, any unused medicine or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Haleon Australia Pty Ltd
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                11 September 2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>